Infectious disease. Early loss of immune cells and progressive immunodeficiency in HIV infection: it's all about the gut [0.03%]
传染病. HIV感染早期免疫细胞的丢失及进行性免疫缺陷：肠道是关键
Edward C Oldfield rd
Edward C Oldfield rd
Definitive therapy for internal hemorrhoids--new opportunities and options [0.03%]
内痔的 definitive治疗——新的机会和选择
Gordon V Ohning,Gustavo A Machicado,Dennis M Jensen
Gordon V Ohning
Hemorrhoids are common in Western societies. Appropriate assessment and treatment of symptomatic hemorrhoids can substantially reduce morbidity and improve patient well-being. In this article, the clinical presentation, differential diagnos...
Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome [0.03%]
用于治疗肠易激综合征的新益生菌Bifidobacterium infantis 35624
Darren M Brenner,William D Chey
Darren M Brenner
Irritable bowel syndrome (IBS) is a common disorder with widespread prevalence. Due to its heterogeneous pathogenesis, efficacious treatments are lacking. The few medications that are effective for treating global IBS symptoms have either b...
Douglas K Rex
Douglas K Rex
The most effective colonoscopy misses polyps, and both barium enema and computed tomography colonography studies have identified hidden areas on the proximal sides of folds, flexures, and valves where colonoscopy can miss even substantially...
Philip O Katz
Philip O Katz
William J Sandborn
William J Sandborn
Infectious disease. Vancomycin should be the drug of choice for severe Clostridium difficile-associated diarrhea [0.03%]
难辨梭状芽胞杆菌感染性腹泻的治疗应首选万古霉素
Edward C Oldfield
Edward C Oldfield
Certolizumab pegol: a polyethylene glycolated Fab' fragment of humanized anti-tumor necrosis factor alpha monoclonal antibody for the treatment of Crohn's disease [0.03%]
certolizumab pegol：治疗克罗恩病的人类单克隆抗肿瘤坏死因子α抗体的聚乙二醇化Fab'片段
Danial E Baker
Danial E Baker
Certolizumab pegol offers an alternative to the other biologic response modifiers for the treatment of Crohn's disease. Results from phase II dose-ranging studies were mixed because a number of the studies had high placebo response rates an...
Girish Anand,Philip O Katz
Girish Anand
Although the balance of epidemiologic data supports a relationship between obesity and gastroesophageal reflux disease (GERD), it is difficult to establish true cause and effect. However, results of several studies show that the frequency a...
Kyu Chan Huh,Douglas K Rex
Kyu Chan Huh
To date, no alternative platform for colonoscopy seems prepared to substantially supplant the traditional colonoscopy platform. The Invendoscope and capsule colonoscopy are the most promising of the alternative platforms. With regard to col...